Suvretta Capital Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $3.33 Billion
- Q3 2025
A detailed history of Suvretta Capital Management, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 6,192,715 shares of EYPT stock, worth $73.4 Million. This represents 2.57% of its overall portfolio holdings.
Number of Shares
6,192,715
Previous 6,804,091
8.99%
Holding current value
$73.4 Million
Previous $64 Million
33.86%
% of portfolio
2.57%
Previous 2.2%
Shares
17 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$45 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...